myeloMATCH Treatment Trials

MyeloMATCH is a group of clinical trials for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS). These trials test new precision medicine treatments for patients with myeloid cancers, from diagnosis through multiple stages of their treatment journey.

myeloMATCH Links Additional Resources
myeloMATCH: Precision Medicine in Myeloid Cancer - AML | MDS

The myeloMATCH trial's screening protocol opened in May 2024.

New myeloMATCH treatment trials (sub-studies) will be opened regularly. The treatment trials below have just opened or will be opening shortly.